Well, your guesses are probably better than mine.
IMO, the board (and certainly me) would be interested in hearing "what is being prototyped", what blue-sky ideas are being seriously considered for their mass-market potential.
IMO:
1. the future of medical testing is chip-based arrays of protiens/RNA/DNA
2. medical devices, surgical tools, and implants will continue to get steadily smaller, until they can operate on the scale that the body does: the scale of large molecules. The semiconductor industry has the only mass-production methods available, to make things on that scale.
3. At some point (my guess is, around 2010-2020) the growth sectors of the economy will change, from being silicon/photon/software-based, to being protein/DNA-based. It's still too early to get into biotech, that sector still is mostly promise and scant profits, the current boom will go on to another bust. But, the next tech company with the size of market cap last seen in 2000 by CSCO, INTC, and MSFT, will be a biotech company. |
